York Health Economics Consortium

Name

York Health Economics Consortium

Legal name

York Health Economics Consortium

Website

https://yhec.co.uk

Company type

Private

Founded year

1986

Operating status

Operating

Ownership category

akta.pro rank

Product category

Health Economics Consultancy

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN)

akta.pro secondary industries

Economic Evaluation & Health Technology Assessment (Public Programs) (HLAJANAL), Health Technology Assessment (HTA) & Reimbursement Policy Bodies (HLAJACAF), Real-World Evidence (RWE) & HEOR for Development (HLAIALAI), Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)

Keywords

• Health economics consultancy
• Health technology assessment
• Economic modelling services
• Evidence synthesis research
• Outcomes research consultancy

Headquarters

HQ city

York

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Health Economics Consultancy Services: YHEC provides commissioned consultancy services to public and private sector clients, including pharmaceutical companies, medical device manufacturers, digital health companies, NHS organisations, and government bodies. Services include health economic evaluation, HTA submissions, evidence synthesis, and outcomes research.
2. Training Courses: YHEC offers open training courses and bespoke training programs. To mark their 40th anniversary in 2026, all open training courses are offered free of charge. Bespoke training continues as a paid service.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

York Health Economics Consortium (YHEC) is a health economics consultancy that delivers commissioned professional services including health economic evaluation, health technology assessment (HTA) submissions, literature reviews and evidence synthesis, statistical analysis, outcomes research, and medical communications to pharmaceutical, medical technology, digital health, diagnostics, and rare disease clients, as well as NHS and public sector organisations. It also offers open and bespoke training courses and self-funded research, delivered by a 70+ person team based at the University of York.

Product overview

York Health Economics Consortium (YHEC) is a health economics consultancy offering a portfolio of professional services rather than a unified software product. The core offerings include Health Economic Evaluation, Literature Reviews & Evidence Synthesis, Health Technology Assessment (HTA), Outcomes Research, Statistics, Environmental Impact assessment, Medical Communications, Bespoke Training & Support, and Self-Funded Research. These services are delivered by a team of over 70 health economists, modellers, outcome researchers, statisticians, and information specialists. YHEC also provides expert-led Training Courses covering economic modelling, statistics, environmental sustainability, and evidence synthesis. Knowledge products include Publications & Reports and a Health Economics Glossary. The firm operates from the University of York and serves pharmaceutical, digital health, medical technology, diagnostics, and rare disease sectors, as well as healthcare systems and public sector organizations including NICE.

Differentiator

Problem solved

Functional benefit

Products and services

• Health Economic Evaluation Provides high-quality, flexible health economic models (cost-effectiveness, budget impact, early economic models) to inform industry and health system decision-making, supporting market access and resource optimisation.
• Literature Reviews & Evidence Synthesis

Quantifiable outcome

• 150+ projects per year
• +4 more outcomes

Named customers6 records

Segments7 records

Ideal customer profiles7 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered core and major.

• The London School of Hygiene & Tropical MedicinecoreStrategic or Co-development PartnerCollaboration with The London School of Hygiene & Tropical Medicine and Flo Health on peer-reviewed research published in npj Digital Medicine. The study evaluated the economic impact of Flo Health's digital symptom checker for endometriosis, finding potential cost savings of $5,196 per person over 40 years.
• NICE (National Institute for Health and Care Excellence)coreStrategic or Co-development PartnerYHEC serves as an External Assessment Group (EAG) for NICE's HealthTech programme since 2010, providing methodological support for evaluating devices and diagnostics. Previously served as Economic and Methodological Unit for Public Health and Social Care Centre (2015-2022) and as National Collaborating Centre for Indicator Development (2009-2017).
• National Pharmacy AssociationmajorStrategic or Co-development PartnerCommissioned by the National Pharmacy Association to conduct research on community pharmacy services. Study found expanding these services could help NHS in England save around £1.21 billion through reduced hospital admissions, deprescribing, and improved medicine adherence.
• University of YorkcoreStrategic or Co-development PartnerYHEC is wholly owned by the University of York. Benefits from close ties with Centre for Health Economics, Centre for Reviews and Dissemination, and Department of Health Sciences. This unique positioning allows bridging between cutting-edge academic research and real-world application.
• Health Innovation Yorkshire & HumbermajorStrategic or Co-development PartnerPartnership on impact reporting and economic analysis. YHEC contributed to the Health Innovation Yorkshire & Humber Impact Report 2024-25.
• Department of Health and Social CaremajorStrategic or Co-development PartnerYHEC provides fast-response research through the Partnership for Responsive Policy Analysis and Research (PREPARE) to inform developing policy. One of YHEC's board members has spent 11 years co-leading this initiative.
• Centre for Health Economics (University of York)coreStrategic or Co-development PartnerYHEC recommends longer and more advanced workshops through the University of York's Centre of Health Economics for post-graduate programmes.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Putnam Associates: Global strategy consulting firm focused on biopharma with a dedicated HEOR and market access capability. Competes with YHEC on economic modelling and HTA strategy for pharma clients, with broader commercial strategy overlay.
• Charles River Associates (Life Sciences Practice): Global consulting firm with a Life Sciences practice that delivers HEOR, pricing, and market access services. Overlaps with YHEC's pharmaceutical and biotech consulting, but operates as a broader strategy firm.

Direct peers

• Mtech Access: UK-based health economics and market access consultancy providing HTA submissions, payer engagement, and value communications. Closely comparable in scale and customer base to YHEC.
• Evidera (PPD / Thermo Fisher Scientific): Major global HEOR and RWE consultancy operating within Thermo Fisher's clinical research business. Competes with YHEC on HTA evidence generation, economic modelling, and outcomes research for global pharma clients.
• Pharmerit International (now part of OPEN Health): HEOR and market access consultancy (now integrated with OPEN Health) competing with YHEC on economic modelling, RWE, and HTA evidence generation for global pharma clients.
• BresMed Health Solutions: UK-based health economics and outcomes research consultancy offering HTA submissions, economic modelling, and systematic reviews. Closest direct UK competitor to YHEC, serving many of the same pharma and NHS clients.
• Office of Health Economics (OHE): UK-based independent health economics research organisation with strong academic and policy linkages. Competes with YHEC on HTA research, economic evaluation, and policy advisory work for pharma and government clients.
• OPEN Health Group: Global HEOR, market access, and medical communications consultancy serving pharma and MedTech. Direct competitor to YHEC across HTA submissions, evidence synthesis, and economic modelling, but at significantly larger scale and broader geographic footprint.
• Abacus International: UK-based market access and HEOR consultancy supporting pharma HTA submissions and value communications. Direct competitor to YHEC's Pharmaceutical and MedTech segments.

Others

• NICE Scientific Advice: NICE's fee-for-service scientific advice arm that provides early HTA consultation to pharma and medtech developers. Adjacent rather than competing — they are a customer/partner ecosystem participant that complements YHEC's downstream HTA submission work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/YHEC1
• Facebookfacebook.com/yorkhealtheconomicsconsortium
• LinkedInlinkedin.com/company/york-health-economics-consortium

Revenue estimate

Valuation estimate

Number of profiles

Profiles20 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about York Health Economics Consortium